Experimental Methyl Mercury Neurotoxicity: Locus of Mercurial Inhibition of Brain Protein Synthesis In Vivo and In Vitro

Abstract

Brain cell‐free protein synthesis is inhibited by methyl mercury chloride (MeHg) following in vivo or in vitro administration. In this report, we have identified the locus of mercurial inhibition of translation. Intraperitoneal injection of MeHg (40 nmol/g body wt) induced variable inhibition of amino acid incorporation into the postmitochondrial supernatant (PMS) harvested from the brain of young (10‐20‐day‐old) rats. No mercurial‐induced disaggregation of brain polyribosomes nor change in the proportion of 80S monoribosomes was detected on sucrose density gradients. No difference in total RNA was found in the PMS. Initiation complex formation was stimulated by MeHg, as detected by radiolabelled methionine binding to 80S monoribosomes following continuous sucrose density gradient centrifugation. After micrococcal nuclease digestion of endogenous mRNA, both in vivo and in vitro MeHg inhibited polyuridylic acid‐directed incorporation of [³H]phenylalanine. However, the in vivo inhibition was no longer observed when [³H]phenylalanyl‐tRNA^Phe replaced free [³H]phenylalanine in the incorporation assay. The formation of peptidyl[³H]puromycin revealed no difference from controls. There was significant mercurial inhibition of phenylalanyl‐tRNA^Phe synthetase activity in pH 5 enzyme fractions derived from brain PMS of MeHg‐poisoned rats. These experiments revealed that the apparent MeHg inhibition of brain translation in vivo and in vitro is due primarily to perturbation in the aminoacylation of tRNA and is not associated with defective initiation, elongation, or ribosomal function.